Skip to main content
Login
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

Biopharmaceuticals Latigo Biotherapeutics Sends IPO Request to SEC in Nasdaq

Summary by Globo
Latigo Biotherapeutics, a clinical biopharmaceutical company (which tests in humans), signed on Friday (17), with the Securities and Exchange Commission (SEC), a request for an initial public offer of shares (IPO). The company's document based in Thousand Oaks, California, does not indicate how many shares it plans to sell or the amount it intends to collect. Exclusive material for subscribers. To have full access, access the link of the subject…

1 Articles

GloboGlobo
Lean Right

Biopharmaceuticals Latigo Biotherapeutics Sends IPO Request to SEC in Nasdaq

Latigo Biotherapeutics, a clinical biopharmaceutical company (which tests in humans), signed on Friday (17), with the Securities and Exchange Commission (SEC), a request for an initial public offer of shares (IPO). The company's document based in Thousand Oaks, California, does not indicate how many shares it plans to sell or the amount it intends to collect. Exclusive material for subscribers. To have full access, access the link of the subject…

·Rio de Janeiro, Brazil
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Right
100% Right

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Globo broke the news in Rio de Janeiro, Brazil on Friday, July 17, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Thousand Oaks icon

Thousand Oaks

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal